Procter & GamblePGBUYDec 15, 2025Stock price when the opinion was issued
As of Jun 04, 2026. Market Open.
Owns neither. Of the two, he'd prefer JNJ. Hesitant to put them in the same basket. With spinoff of healthcare, it's now much more into pharmaceuticals (doing very well) and medical devices. Valuation is not that demanding. Executing well.
PG is a consumer products company. Consumer is in some difficulty, and jury's out as to whether we've seen the worst of that dip.
These consumer stocks are facing inflation. Revenue growth has been low, 3% the last quarter. Margins remain strong, though. Never been cheaper. Pays a 3% dividend. He isn't that bullish on the consumer, but PG is defensive. A good time to buy now, but don't expect a huge return, like 5-10% share appreciation + dividend.
They use tech to fix the supply chain, and use AI to reduce supplies they don't need. Also, the stock is down 13% this year and management said it will miss the quarter. Shares are on sale. Cheap at 20x PE and pays a 2.9% dividend.